State of Tennessee Treasury Department boosted its stake in shares of ICU Medical Inc. (NASDAQ:ICUI) by 2.8% during the third quarter, Holdings Channel reports. The firm owned 11,580 shares of the company’s stock after buying an additional 315 shares during the period. State of Tennessee Treasury Department’s holdings in ICU Medical were worth $1,463,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the company. Checchi Capital Advisers LLC bought a new stake in shares of ICU Medical during the second quarter worth about $242,000. Smith Asset Management Group LP raised its stake in shares of ICU Medical by 2.3% in the second quarter. Smith Asset Management Group LP now owns 25,782 shares of the company’s stock worth $2,907,000 after buying an additional 590 shares during the period. Strs Ohio raised its stake in shares of ICU Medical by 6.3% in the second quarter. Strs Ohio now owns 10,200 shares of the company’s stock worth $1,150,000 after buying an additional 600 shares during the period. Diversified Trust Co bought a new stake in shares of ICU Medical during the second quarter worth about $237,000. Finally, Moody Aldrich Partners LLC raised its stake in shares of ICU Medical by 166.4% in the second quarter. Moody Aldrich Partners LLC now owns 11,215 shares of the company’s stock worth $1,264,000 after buying an additional 7,005 shares during the period. 88.20% of the stock is currently owned by institutional investors.
Shares of ICU Medical Inc. (NASDAQ:ICUI) remained flat at $134.50 during midday trading on Thursday. The company’s stock had a trading volume of 161,747 shares. The firm has a 50 day moving average price of $144.59 and a 200 day moving average price of $133.26. ICU Medical Inc. has a 1-year low of $85.56 and a 1-year high of $154.80. The stock has a market capitalization of $2.20 billion, a PE ratio of 38.78 and a beta of 0.34.
ICU Medical (NASDAQ:ICUI) last released its earnings results on Wednesday, November 9th. The company reported $1.35 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.17 by $0.18. ICU Medical had a return on equity of 10.70% and a net margin of 15.18%. The company had revenue of $97.11 million for the quarter, compared to analysts’ expectations of $93.04 million. During the same quarter in the previous year, the business posted $1.00 EPS. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, equities research analysts expect that ICU Medical Inc. will post $4.84 EPS for the current year.
Separately, Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $163.00 target price on the stock in a research report on Monday, January 2nd.
In other ICU Medical news, Director Robert S. Swinney sold 2,025 shares of ICU Medical stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $142.88, for a total transaction of $289,332.00. Following the transaction, the director now owns 16,850 shares of the company’s stock, valued at approximately $2,407,528. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 15.90% of the company’s stock.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical Inc. (NASDAQ:ICUI).